BioNTech anticipates €1.6-€1.9 billion revenue in 2026 BioNTech forecasts revenue between €1.6 and €1.9 billion for 2026. The company is advancing its oncology catalysts into late 2026. BioNTech's leadership transition is tied to commercialization scale, wi
BioNTech anticipates €1.6-€1.9 billion revenue in 2026
BioNTech forecasts revenue between €1.6 and €1.9 billion for 2026.
The company is advancing its oncology catalysts into late 2026.
BioNTech’s leadership transition is tied to commercialization scale, with Guido Oelkers set to take office as CEO by February 1.
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.
